4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-076897
Options or other derivatives
- Director acquired 710,711 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Noble James Director | 2022-07-01 | Grant or award · Option to purchase Ordinary Shares | +710,711 | 710,711 | D | ||
Loading xslF345X03/tm2220260-4_4seq1.xml…